Cargando…

Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases

BACKGROUND: Transpulmonary thermodilution is recommended in the treatment of critically ill patients presenting with complex shock. However, so far it has not been validated in hemodynamically stable patients with heart disease. METHODS: We assessed the validity of cardiac output, global end-diastol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilty, Matthias Peter, Franzen, Daniel Peter, Wyss, Christophe, Biaggi, Patric, Maggiorini, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567579/
https://www.ncbi.nlm.nih.gov/pubmed/28831765
http://dx.doi.org/10.1186/s13613-017-0307-0
_version_ 1783258749191847936
author Hilty, Matthias Peter
Franzen, Daniel Peter
Wyss, Christophe
Biaggi, Patric
Maggiorini, Marco
author_facet Hilty, Matthias Peter
Franzen, Daniel Peter
Wyss, Christophe
Biaggi, Patric
Maggiorini, Marco
author_sort Hilty, Matthias Peter
collection PubMed
description BACKGROUND: Transpulmonary thermodilution is recommended in the treatment of critically ill patients presenting with complex shock. However, so far it has not been validated in hemodynamically stable patients with heart disease. METHODS: We assessed the validity of cardiac output, global end-diastolic volume index (GEDVI), an established marker of preload thought to reflect the volume of all four heart chambers, global ejection fraction (GEF) and cardiac function index (CFI) as variables of cardiac function, and extravascular lung water index (EVLWI) as indicator of pulmonary edema in 29 patients undergoing elective left and right heart catheterization including left ventricular angiography with stable coronary heart disease and normal cardiac function (controls, n = 11), moderate-to-severe aortic valve stenosis (AS, n = 10), or dilated cardiomyopathy (DCM, n = 8). RESULTS: Cardiac output was similar in controls, AS, and DCM, with good correlation between transpulmonary thermodilution and pulmonary artery catheter using the Fick method (r = 0.69, p < 0.0001). Left ventricular end-diastolic volume was normal in controls and AS, but significantly higher in DCM (104 ± 37 vs 135 ± 63 vs 234 ± 24 ml, p < 0.01). GEDVI did not differentiate between patients with normal and patients with enlarged left ventricular end-diastolic volume (848 ± 128 vs 882 ± 213 ml m(−2), p = 0.60). No difference in GEF and CFI was found between patients with normal and patients with reduced left ventricular ejection fraction. Patients with AS but not DCM had higher EVLWI than controls (9 ± 2 vs 12 ± 4 vs 11 ± 3 ml kg(−1), p = 0.04), while there was only a trend in pulmonary artery occlusion pressure (8 ± 3 vs 10 ± 5 vs 14 ± 7 mmHg, p = 0.05). CONCLUSIONS: Cardiac output measurement by transpulmonary thermodilution is unaffected by differences in ventricular size and outflow obstruction. However, GEDVI did not identify markedly enlarged left ventricular end-diastolic volumes, and neither GEF nor CFI reflected the increased heart chamber volumes and markedly impaired left ventricular function in patients with DCM. In contrast, EVLWI is probably a sensitive marker of subclinical pulmonary edema particularly in patients with elevated left-ventricular-filling pressure irrespective of differences in left ventricular function.
format Online
Article
Text
id pubmed-5567579
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55675792017-09-11 Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases Hilty, Matthias Peter Franzen, Daniel Peter Wyss, Christophe Biaggi, Patric Maggiorini, Marco Ann Intensive Care Research BACKGROUND: Transpulmonary thermodilution is recommended in the treatment of critically ill patients presenting with complex shock. However, so far it has not been validated in hemodynamically stable patients with heart disease. METHODS: We assessed the validity of cardiac output, global end-diastolic volume index (GEDVI), an established marker of preload thought to reflect the volume of all four heart chambers, global ejection fraction (GEF) and cardiac function index (CFI) as variables of cardiac function, and extravascular lung water index (EVLWI) as indicator of pulmonary edema in 29 patients undergoing elective left and right heart catheterization including left ventricular angiography with stable coronary heart disease and normal cardiac function (controls, n = 11), moderate-to-severe aortic valve stenosis (AS, n = 10), or dilated cardiomyopathy (DCM, n = 8). RESULTS: Cardiac output was similar in controls, AS, and DCM, with good correlation between transpulmonary thermodilution and pulmonary artery catheter using the Fick method (r = 0.69, p < 0.0001). Left ventricular end-diastolic volume was normal in controls and AS, but significantly higher in DCM (104 ± 37 vs 135 ± 63 vs 234 ± 24 ml, p < 0.01). GEDVI did not differentiate between patients with normal and patients with enlarged left ventricular end-diastolic volume (848 ± 128 vs 882 ± 213 ml m(−2), p = 0.60). No difference in GEF and CFI was found between patients with normal and patients with reduced left ventricular ejection fraction. Patients with AS but not DCM had higher EVLWI than controls (9 ± 2 vs 12 ± 4 vs 11 ± 3 ml kg(−1), p = 0.04), while there was only a trend in pulmonary artery occlusion pressure (8 ± 3 vs 10 ± 5 vs 14 ± 7 mmHg, p = 0.05). CONCLUSIONS: Cardiac output measurement by transpulmonary thermodilution is unaffected by differences in ventricular size and outflow obstruction. However, GEDVI did not identify markedly enlarged left ventricular end-diastolic volumes, and neither GEF nor CFI reflected the increased heart chamber volumes and markedly impaired left ventricular function in patients with DCM. In contrast, EVLWI is probably a sensitive marker of subclinical pulmonary edema particularly in patients with elevated left-ventricular-filling pressure irrespective of differences in left ventricular function. Springer International Publishing 2017-08-22 /pmc/articles/PMC5567579/ /pubmed/28831765 http://dx.doi.org/10.1186/s13613-017-0307-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Hilty, Matthias Peter
Franzen, Daniel Peter
Wyss, Christophe
Biaggi, Patric
Maggiorini, Marco
Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title_full Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title_fullStr Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title_full_unstemmed Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title_short Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
title_sort validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567579/
https://www.ncbi.nlm.nih.gov/pubmed/28831765
http://dx.doi.org/10.1186/s13613-017-0307-0
work_keys_str_mv AT hiltymatthiaspeter validationoftranspulmonarythermodilutionvariablesinhemodynamicallystablepatientswithheartdiseases
AT franzendanielpeter validationoftranspulmonarythermodilutionvariablesinhemodynamicallystablepatientswithheartdiseases
AT wysschristophe validationoftranspulmonarythermodilutionvariablesinhemodynamicallystablepatientswithheartdiseases
AT biaggipatric validationoftranspulmonarythermodilutionvariablesinhemodynamicallystablepatientswithheartdiseases
AT maggiorinimarco validationoftranspulmonarythermodilutionvariablesinhemodynamicallystablepatientswithheartdiseases